Physician profile
Michael K Lee
NPI 1427302256
$5,942.06
in general payments reported to CMS, 2019-2025
22 companies · $661 in 2025
The $661 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $244 · 2020: $450 · 2021: $671 · 2022: $701 · 2023: $289 · 2024: $2,926 · 2025: $661.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,500 · Food and Beverage: $1,376 · Consulting Fee: $1,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,500.00 |
| Food and Beverage | $1,375.96 |
| Consulting Fee | $1,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Motiva USA, LLC | $2,699.44 | 2024-2025 | |
| Mentor Worldwide LLC | $877.95 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Sientra, INC. | $752.84 | 2020-2022 | |
| Apyx Medical Corporation | $334.94 | 2019-2020 | |
| Integra Lifesciences Corporation | $320.95 | 2021-2025 | Integra, Omnigraft, Surgimend |
| Abbvie INC. | $186.70 | 2024-2025 | |
| Rti Surgical, INC | $150.00 | 2025 | |
| Allergan, INC. | $121.21 | 2019-2021 | |
| Tela Bio, INC. | $89.59 | 2021-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Revance Therapeutics, INC. | $73.14 | 2024-2025 | Daxxify |
| Davol INC. | $63.58 | 2021-2022 | |
| Pacira Pharmaceuticals Incorporated | $44.58 | 2022 | |
| Axogen | $31.09 | 2025 | |
| Baxter Healthcare | $30.66 | 2021 | |
| Avanos Medical | $28.01 | 2023 | On-Q* Pump and Accessories |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $23.58 | 2019 | |
| Depuy Synthes Sales INC. | $22.72 | 2019 | |
| Medline Industries LP | $20.91 | 2020 | |
| Convatec INC. | $19.47 | 2019 | |
| Acell, INC. | $18.08 | 2020 | |
| Galderma Laboratories, L.P. | $18.01 | 2025 | |
| Medtronic USA, INC. | $14.61 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.